Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Trends Pharmacol Sci. 2015 Dec 17;37(1):73–84. doi: 10.1016/j.tips.2015.10.002

Figure 4.

Figure 4

CGP3466B exerts its neuroprotective effect via inhibition of SNO-GAPDH formation. S-Nitrosylation of GAPDH enhances its interaction with Siah1 (bearing a nuclear localization signal) and promotes its translocation to the nucleus, whereas SNO-GAPDH triggers cellular events leading to neurodegeneration. CGP3466B (TCH346 or Omigapil) potently and selectively blocks GAPDH S-nitrosylation and thereby Siah binding.